ETF盘中资讯 创新药深度回调，可以上车吗？高人气520880跌逾3%，溢价高企，近4日吸金6.7亿元

Group 1 - The core viewpoint of the news is that the Hong Kong Stock Connect Innovative Drug ETF (520880) has experienced a significant price drop of 3.38%, despite a strong buying interest indicated by a premium rate of 0.46% [1] - The ETF has seen a net inflow of 673 million yuan over the past four days, bringing its total size to 974 million yuan, which is a 124% increase since its launch on July 7 [1][3] - The ETF passively tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index, focusing on the innovative drug industry chain with a high concentration of leading companies [4] Group 2 - The Hang Seng Hong Kong Stock Connect Innovative Drug Select Index has risen by 101.58% year-to-date as of July 31, significantly outperforming other indices such as the Hang Seng Index (23.50%) and the Hang Seng Technology Index (22.05%) by 78.08 and 79.53 percentage points, respectively [7] - The index has shown a strong performance since its inception, with a base date of December 31, 2020, and has been adjusted according to its compilation rules [7] - Institutions believe that the innovative drug sector is entering a recovery phase, supported by improving policies and the maturation of research pipelines, indicating a potential for valuation re-rating in the pharmaceutical sector [8]